Advances in hepatic arterial perfusion chemotherapy for hepatic metastases

Hepatic arterial infusion chemotherapy (HAIC) is one of the local treatment modalities employed for liver metastases. HAIC targets the delivery of chemotherapy drugs to the affected area by inserting a catheter into the tumor’s blood-supplying artery. This approach not only enhances drug concentrati...

Full description

Saved in:
Bibliographic Details
Main Authors: Haodi Ou, Xiaodong Li, Shulin Chang, Guijie Li, Feng Chen, Song Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1544061/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849471504360669184
author Haodi Ou
Haodi Ou
Xiaodong Li
Xiaodong Li
Shulin Chang
Shulin Chang
Guijie Li
Feng Chen
Song Jiang
author_facet Haodi Ou
Haodi Ou
Xiaodong Li
Xiaodong Li
Shulin Chang
Shulin Chang
Guijie Li
Feng Chen
Song Jiang
author_sort Haodi Ou
collection DOAJ
description Hepatic arterial infusion chemotherapy (HAIC) is one of the local treatment modalities employed for liver metastases. HAIC targets the delivery of chemotherapy drugs to the affected area by inserting a catheter into the tumor’s blood-supplying artery. This approach not only enhances drug concentration within the tumor site, but also significantly reduces systemic side effects. Currently, there are various chemotherapeutic regimens available for HAIC in liver metastases; however, determining the optimal therapeutic agent remains elusive. This article provides a comprehensive review of HAIC dosing regimens and multimodal therapy for liver metastases originating from colorectal, breast, and gastric cancers. Meanwhile, this paper briefly outlines ongoing research on HAIC treatment for liver metastases associated with esophageal cancer, gastroenteropancreatic neuroendocrine tumors, and uveal melanoma.
format Article
id doaj-art-c0a079f16ace4d069582a87f7f4b637c
institution Kabale University
issn 2234-943X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-c0a079f16ace4d069582a87f7f4b637c2025-08-20T03:24:48ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-06-011510.3389/fonc.2025.15440611544061Advances in hepatic arterial perfusion chemotherapy for hepatic metastasesHaodi Ou0Haodi Ou1Xiaodong Li2Xiaodong Li3Shulin Chang4Shulin Chang5Guijie Li6Feng Chen7Song Jiang8Department of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan, ChinaGraduate school, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan, ChinaGraduate school, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan, ChinaGraduate school, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, ChinaDepartment of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan, ChinaDepartment of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan, ChinaDepartment of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Abdominal Medicine Imaging, Jinan, ChinaHepatic arterial infusion chemotherapy (HAIC) is one of the local treatment modalities employed for liver metastases. HAIC targets the delivery of chemotherapy drugs to the affected area by inserting a catheter into the tumor’s blood-supplying artery. This approach not only enhances drug concentration within the tumor site, but also significantly reduces systemic side effects. Currently, there are various chemotherapeutic regimens available for HAIC in liver metastases; however, determining the optimal therapeutic agent remains elusive. This article provides a comprehensive review of HAIC dosing regimens and multimodal therapy for liver metastases originating from colorectal, breast, and gastric cancers. Meanwhile, this paper briefly outlines ongoing research on HAIC treatment for liver metastases associated with esophageal cancer, gastroenteropancreatic neuroendocrine tumors, and uveal melanoma.https://www.frontiersin.org/articles/10.3389/fonc.2025.1544061/fullHAIChepatic metastasestreatmentchemotherapylocoregional therapy
spellingShingle Haodi Ou
Haodi Ou
Xiaodong Li
Xiaodong Li
Shulin Chang
Shulin Chang
Guijie Li
Feng Chen
Song Jiang
Advances in hepatic arterial perfusion chemotherapy for hepatic metastases
Frontiers in Oncology
HAIC
hepatic metastases
treatment
chemotherapy
locoregional therapy
title Advances in hepatic arterial perfusion chemotherapy for hepatic metastases
title_full Advances in hepatic arterial perfusion chemotherapy for hepatic metastases
title_fullStr Advances in hepatic arterial perfusion chemotherapy for hepatic metastases
title_full_unstemmed Advances in hepatic arterial perfusion chemotherapy for hepatic metastases
title_short Advances in hepatic arterial perfusion chemotherapy for hepatic metastases
title_sort advances in hepatic arterial perfusion chemotherapy for hepatic metastases
topic HAIC
hepatic metastases
treatment
chemotherapy
locoregional therapy
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1544061/full
work_keys_str_mv AT haodiou advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT haodiou advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT xiaodongli advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT xiaodongli advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT shulinchang advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT shulinchang advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT guijieli advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT fengchen advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases
AT songjiang advancesinhepaticarterialperfusionchemotherapyforhepaticmetastases